NDC 55466-149-22 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55466-149
- Requested NDC
- 55466-149-22
- Package NDCs from labels
- 55466-149-22
- Manufacturer
- Neolpharma, Inc.
- Effective date
- 2024-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Neolpharma, Inc. | Neolpharma, Inc. | 2024-05-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55466-149-22 | Oseltamivir Phosphate | 10 in 1 BOTTLE | CAPSULE | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Novadoz Pharmaceuticals LLC | c456f293-daf7-46b1-bffc-5ca234adbb70 | 2026-02-06 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | NuCare Pharmaceuticals, Inc. | 497adf7b-9bdc-314e-e063-6394a90a63be | 2026-01-28 | Warnings, Adverse reactions | 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | 9dac3ba2-b667-4081-9395-8db45d38ceac | 2026-01-28 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | AvKARE | 7d8ce967-8037-9fd5-e053-2991aa0a015f | 2026-01-15 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR | AvKARE | c61bb5af-558f-4b32-b34d-8fdae480443c | 2026-01-15 | Warnings, Adverse reactions | 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Redpharm Drug | 2fbd0c56-82bf-f0fa-e063-6294a90a9f2f | 2025-12-30 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Redpharm Drug | 2fd237e8-7ac9-f473-e063-6294a90aadfc | 2025-12-27 | Warnings, Adverse reactions | 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Redpharm Drug | 2fd1d9f7-a4e0-7fda-e063-6294a90ad425 | 2025-12-25 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate for Oral Suspension | OSELTAMIVIR PHOSPHATE | Oryza Pharmaceuticals Inc. | 11cf45d4-0e6c-4408-bbe6-5ed94468cf2e | 2025-12-17 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Tamiflu | OSELTAMIVIR PHOSPHATE | Genentech, Inc. | ee3c9555-60f2-4f82-a760-11983c86e97b | 2025-12-15 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | MSN LABORATORIES PRIVATE LIMITED | 1b7a02ca-ee0e-4853-91e6-71a79f2bc040 | 2025-11-20 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Exelan Pharmaceuticals, Inc. | 31c90a2e-9d14-4236-8dc2-b2a862e8cbac | 2025-10-30 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Zhejiang Poly Pharm. Co., Ltd. | 339778ee-0b6f-6d81-e063-6394a90a2d32 | 2025-10-13 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Lupin Pharmaceuticals, Inc. | b428e1f2-0082-4d9f-908e-e3633ea0457b | 2025-10-07 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Lupin Pharmaceuticals, Inc. | 7dd9f7f2-a887-454a-8d3e-761083b840db | 2025-10-06 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Strides Pharma Science Limited | 39255500-0ffd-4d72-abe8-257570b543e7 | 2025-09-09 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | 16fcbcb4-609c-4d4e-a134-013823207dc7 | 2025-09-04 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Ajanta Pharma USA Inc. | c6f78d2d-6452-4af3-83c6-b044d1604bdc | 2025-08-20 | Warnings, Adverse reactions | 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.